Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis

Frontiers in Immunology(2022)10.3389/fimmu.2022.919802Source: DataRank Database

Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.39)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Farina Karim ORCID,Artur T. L. Queiroz ORCID,Mariana Araújo‐Pereira ORCID,Beatriz Barreto‐Duarte ORCID,Caio Sales

Live enrichment

PubMed:35874781 PMC:PMC9304990 OpenAlex:https://openalex.org/W4285022008

Wellcome Trust

Grant: 210662/Z/18/Z

NIAID NIH HHS

Grant: U01 AI069923

NIAID NIH HHS

Grant: U01 AI115940

Wellcome Trust

Grant: 210662

Investigating the role of lung Tissue resident memory T-cell in the immunopathology of human TB

National Institutes of Health

Grant: 5U01AI115940-04

Inflammatory determinants of disease severity and treatment outcome in TB patients

National Institutes of Health

Grant: 3U01AI069923-04S1

CCASAnet: Caribbean, Central and South America Network

Wellcome Trust

FWCI

0.39

Citation Percentile

0.6%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.919802/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.919802/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.919802/full

journalhttps://doi.org/10.3389/fimmu.2022.919802

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35874781

Fields of Study

Tuberculosis Research and EpidemiologyEicosanoids and Hypertension PharmacologyMetabolomics and Mass Spectrometry Studies0301 basic medicine03 medical and health sciencesAdultDinoprostoneEicosanoidsHumansMycobacterium tuberculosisSouth AfricaTuberculosis, Pulmonary

MeSH Terms

AdultHumansMycobacterium tuberculosisSouth AfricaTuberculosis, PulmonaryDinoprostoneEicosanoids

Keywords

MedicineMetaboliteUrinary systemEicosanoidInternal medicineTuberculosisDiabetes mellitusGlycemicImmunologyEndocrinologyGastroenterologyArachidonic acidChemistryBiochemistryPathologyEnzymeMycobacterium tuberculosisLipid MediatorsAnti-tuberculosis TreatmentDysglycemiaUrinary EicosanoidsAdultPharmacology, Toxicology and PharmaceuticsEpidemiologyFOS: Health sciencesDinoprostoneSouth AfricaHealth SciencesHumansTuberculosis, PulmonaryPharmacologyEpidemiology and Pathogenesis of Pneumocystis PneumoniaFOS: Clinical medicineMechanisms of Drug-Induced HepatotoxicityLife SciencesRC581-607Infectious DiseasesEicosanoidsImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being